196 related articles for article (PubMed ID: 14732359)
1. The antitumor effects of interferon-alpha are maintained in mice challenged with a STAT1-deficient murine melanoma cell line.
Badgwell B; Lesinski GB; Magro C; Abood G; Skaf A; Carson W
J Surg Res; 2004 Jan; 116(1):129-36. PubMed ID: 14732359
[TBL] [Abstract][Full Text] [Related]
2. The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.
Lesinski GB; Anghelina M; Zimmerer J; Bakalakos T; Badgwell B; Parihar R; Hu Y; Becknell B; Abood G; Chaudhury AR; Magro C; Durbin J; Carson WE
J Clin Invest; 2003 Jul; 112(2):170-80. PubMed ID: 12865406
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.
Lesinski GB; Kondadasula SV; Crespin T; Shen L; Kendra K; Walker M; Carson WE
J Natl Cancer Inst; 2004 Sep; 96(17):1331-42. PubMed ID: 15339971
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects.
Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB
Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983
[TBL] [Abstract][Full Text] [Related]
5. IL-12 pretreatments enhance IFN-alpha-induced Janus kinase-STAT signaling and potentiate the antitumor effects of IFN-alpha in a murine model of malignant melanoma.
Lesinski GB; Badgwell B; Zimmerer J; Crespin T; Hu Y; Abood G; Carson WE
J Immunol; 2004 Jun; 172(12):7368-76. PubMed ID: 15187113
[TBL] [Abstract][Full Text] [Related]
6. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha-induced activation of signal transducer and activator of transcription proteins in malignant melanoma.
Carson WE
Clin Cancer Res; 1998 Sep; 4(9):2219-28. PubMed ID: 9748142
[TBL] [Abstract][Full Text] [Related]
8. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Li Y; Song Y; Li P; Li M; Wang H; Xu T; Yu X; Yu Y; Tai Y; Chen P; Cai X; Wang X; Xiang L; Deng R; Zhang X; Gao L; Wang X; Liu J; Cao F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32152220
[TBL] [Abstract][Full Text] [Related]
10. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins.
Zimmerer JM; Lesinski GB; Kondadasula SV; Karpa VI; Lehman A; Raychaudhury A; Becknell B; Carson WE
J Immunol; 2007 Apr; 178(8):4832-45. PubMed ID: 17404264
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression.
Landolfo S; Guarini A; Riera L; Gariglio M; Gribaudo G; Cignetti A; Cordone I; Montefusco E; Mandelli F; Foa R
Hematol J; 2000; 1(1):7-14. PubMed ID: 11920164
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
14. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.
Bromberg JF; Horvath CM; Wen Z; Schreiber RD; Darnell JE
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7673-8. PubMed ID: 8755534
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signal transduction of interferon on the suppression of haematopoietic progenitor cell growth.
Kato K; Kamezaki K; Shimoda K; Numata A; Haro T; Aoki K; Ishikawa F; Takase K; Ariyama H; Matsuda T; Miyamoto T; Nagafuji K; Gondo H; Nakayama K; Harada M
Br J Haematol; 2003 Nov; 123(3):528-35. PubMed ID: 14617019
[TBL] [Abstract][Full Text] [Related]
16. Expression of STAT1 and STAT2 in malignant melanoma does not correlate with response to interferon-alpha adjuvant therapy.
Lesinski GB; Valentino D; Hade EM; Jones S; Magro C; Chaudhury AR; Walker MJ; Carson WE
Cancer Immunol Immunother; 2005 Sep; 54(9):815-25. PubMed ID: 15668815
[TBL] [Abstract][Full Text] [Related]
17. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha.
Zimmerer JM; Lesinski GB; Radmacher MD; Ruppert A; Carson WE
Cancer Immunol Immunother; 2007 Nov; 56(11):1845-52. PubMed ID: 17503042
[TBL] [Abstract][Full Text] [Related]
18. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
[TBL] [Abstract][Full Text] [Related]
19. An indoleamine 2,3-dioxygenase-negative mutant is defective in stat1 DNA binding: differential response to IFN-gamma and IFN-alpha.
Sotero-Esteva WD; Wolfe D; Ferris M; Taylor MW
J Interferon Cytokine Res; 2000 Jul; 20(7):623-32. PubMed ID: 10926204
[TBL] [Abstract][Full Text] [Related]
20. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.
Gimeno R; Lee CK; Schindler C; Levy DE
Mol Cell Biol; 2005 Jul; 25(13):5456-65. PubMed ID: 15964802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
